Blue Sage Capital Successfully Exits Investment in CRI

AUSTIN, Texas — Blue Sage Capital is pleased to announce that it has successfully exited its investment in Controlled Recovery, better known as CRI. Blue Sage was the majority controlling shareholder of CRI. CRI owns and operates the largest facility for non-hazardous oil and gas waste in the United States. Peter Huff, a Founding Board Member of CRI and leader of the deal team, said that “the sale of CRI to R360 Treatment not only provides the company with an opportunity to continue its rapid expansion, but also provides Blue Sage with a very strong return on its invested capital.” John Barnidge, CEO of CRI, said that “Peter Huff and his team at Blue Sage Capital did an incredible job negotiating and closing the sale of CRI to R360 Treatment. I think this represents a great outcome for all parties. Blue Sage was also extremely active providing frontline operational expertise to my team as we jointly built this company.” Wayne Patterson, Founder of Atreides Capital, a co-investor in CRI, said that his firm “enjoyed working with the CRI management team and Blue Sage and was pleased with the outcome of our investment.”

Blue Sage is an Austin, Texas-based private equity firm founded by Peter Huff and Jim McBride. Blue Sage specializes in growth, recapitalization and buyout financings of smaller middle-market companies based in Texas and the Southwest. Most of Blue Sage’s investments are in established, profitable companies with $5-100 million of revenue and $2-8 million of cash flow at the time of investment. Blue Sage invests in a variety of industries, with each initial investment in a company ranging from $5-15 million. The partnership also reserves additional capital for follow-on investments in companies that are already in its portfolio so that these companies can continue to finance their growth via internal expansion as well as strategic acquisitions.

For additional information please visit Blue Sage’s website at www.bluesage.com or contact Peter Huff at (512) 536-1901.